Circulating endothelial progenitor cell numbers are not associated with donor organ age or allograft vasculopathy in cardiac transplant recipients

Atherosclerosis

Volumn 202, Issue 2, 2009, Pages 612-616

  Thomas, H E ^a   Parry, G ^b   Dark, J H ^b   Arthur, H M ^a   Keavney, B D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cardiac allograft vasculopathy; Cardiac transplantation; Endothelial progenitor cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; KINASE DOMAIN RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BONE MARROW; CARDIOVASCULAR RISK; CELL MOTILITY; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; ORGAN DONOR; PRIORITY JOURNAL; STEM CELL; VASCULAR DISEASE;

ADULT; AGE DISTRIBUTION; AGED; CELL COUNT; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 58549101275     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.020     Document Type: Article

References (22)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Eizawa T., Ikeda U., Murakami Y., et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 90 (2004) 685-686
3. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-7
4. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
5. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
6. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
7. Shaffer R.G., Greene S., Arshi A., et al. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry Part B-Clin Cytometry 70 (2006) 56-62
8. Tao J., Wang Y., Yang Z., et al. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 20 (2006) 490-495
9. Thijssen D.H.J., Vos J.B., Verseyden C., et al. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 5 (2006) 495-503
10. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1. Circ Res 100 (2007) 434-443
11. Scheubel R.J., Zorn H., Silber R.E., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am College Cardiol 42 (2003) 2073-2080
12. Chang E.I., Loh S.A., Ceradini D.J., et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 116 (2007) 2818-2829
13. Rivard A., Berthou-Soulie L., Principe N., et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275 (2000) 29643-29647
14. Hoffmann J., Haendeler J., Aicher A., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89 (2001) 709-715
15. Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Heart Transplant Report-2005, J Heart Lung Transplant, 2005;24:945-955.
16. Simper D., Wang S., Deb A., et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 108 (2003) 143-149
17. George J., Shmilovich H., Deutsch V., et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 12 (2006) 331-335
18. Tura O., Barclay G.R., Roddie H., Davies J., and Turner M.L. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources. J Translational Med 5 (2007) 37
19. Kissel C.K., Lehmann R., Assmus B., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am College Cardiol 49 (2007) 2341-2349
20. Case J., Mead L.E., Bessler W.K., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35 (2007) 1109-1118
21. Sieveking D.P., Buckle A., Celermajer D.S., and Ng M.K.C. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations. Insights from a novel human angiogenesis assay. J Am College Cardiol 51 (2008) 660-668
22. Ingram D.A., Mead L.E., Moore D.B., et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105 (2005) 2783-2786